CHASE THERAPEUTICS
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
CHASE THERAPEUTICS
Industry:
Medical Medical Device Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.chasetherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(202) 223-7002
Total Funding:
25.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Synthon Chiragenics Corp.
Synthon Chiragenics Corp. is a world-leader in carbohydrate-based chiral technology for pharmaceuticals
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Founder
Investors List
China Link Capital
China Link Capital investment in Series B - Chase Therapeutics
Revolution
Revolution investment in Venture Round - Chase Therapeutics
Revolution’s Rise of the Rest Seed Fund
Revolution’s Rise of the Rest Seed Fund investment in Venture Round - Chase Therapeutics
Official Site Inspections
http://www.chasetherapeutics.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
- Host name: s277.sureserver.com
- IP address: 192.252.144.27
- Location: Waltham United States
- Latitude: 42.3972
- Longitude: -71.2434
- Metro Code: 506
- Timezone: America/New_York
- Postal: 02451
More informations about "Chase Therapeutics"
Board of Directors - Chase Therapeutics
He was founding president and executive director of Accelerate Brain Cancer Cure, Inc. (ABC 2) from 2001-2006. ABC 2 is a non-profit organization dedicated to accelerating therapies for …See details»
Management - Chase Therapeutics
Board Chair Kathleen Clarence-Smith, MD, PhD, is a neurologist whose career has been dedicated to identifying, selecting for development new pharmaceuticals, and shepherding …See details»
Chase Therapeutics - Crunchbase Company Profile & Funding
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.See details»
Chase Therapeutics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Chase Therapeutics Corporation of Washington, DC. Get the latest business insights from Dun & …See details»
Chase Theraputics Company Profile | Management and Employees …
Find contact information for Chase Theraputics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Chase Theraputics's email format.See details»
Chase Therapeutics | VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Chase Therapeutics Corp.: Drug pipelines, Patents, Clinical trials ...
Aug 2, 2023 Explore Chase Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, Disease Domain:Nervous System Diseases ...See details»
Home | Cha Therapeutics
Nov 13, 2019 Cha Therapeutics Inc. is an early-stage, privately held, Massachusetts-based biotechnology start-up developing a proprietary epigenetic therapy that improves cancer patient outcomes. Our mission is to develop …See details»
Overview - Chase Therapeutics
The Company is driven by a passion to improve the lives of underserved populations afflicted by central nervous system dysfunction through transformative rather than incremental therapeutic innovation. Chase …See details»
Chase Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Chase Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Chase Therapeutics - Biotech Careers
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.See details»
Chase Therapeutics - Funding, Financials, Valuation & Investors
In funding over 4 rounds. Their latest funding was raised on Oct 20, 2021 from a Series B round. Chase Therapeutics is funded by 4 investors. China Link Capital and Brain Trust Accelerator …See details»
Chase Therapeutics - Craft
Chase Therapeutics is a pharmaceutical company focused on the development of treatments for brain diseases. It provides products for those affected by central nervous system disorders …See details»
Partnering - Chase Therapeutics
Chase Therapeutics essentially operates as a virtual organization. The company finds resource support with individual investigators and research institutions as well as with pharmaceutical …See details»
Chase Theraputics - Overview, News & Similar companies
View Chase Theraputics (www.chasetherapeutics.com) location in District of Columbia, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Chase, after selling last biotech to Allergan, gets cash to start ...
Oct 20, 2021 Chase Therapeutics is heading into pivotal trials. Armed with $20 million, the biotech plans to start phase 3 clinical trials of candidates based on an old Boehringer …See details»
Chase Therapeutics - Golden
Chase Therapeutics is a Washington, D.C.-based company.See details»
Contact - Chase Therapeutics
Chase Therapeutics welcomes all inquiries and will respond to requests for information with prompt and attentive service. Please use the contact form.See details»
Inside the futuristic biotech startup Cellares that’s ... - Fortune
2 days ago The company has now raised $355 million in funding, and signed a $380 million deal last year to reserve manufacturing capacity for Bristol Myers Squibb’s cell therapy drugs. But …See details»
Product Discovery and Development - Chase Therapeutics
The Chase drug development pipeline shows our unique approach to products targeting palliative and neuroprotective treatment of brain diseaseSee details»